| circulatory system process | GO:0003013 | 87 | 0.904 | |
| blood circulation | GO:0008015 | 87 | 0.891 | |
| heart process | GO:0003015 | 71 | 0.887 | |
| heart development | GO:0007507 | 313 | 0.642 | |
| regulation of blood circulation | GO:1903522 | 32 | 0.626 | |
| heart contraction | GO:0060047 | 71 | 0.591 | |
| heart morphogenesis | GO:0003007 | 156 | 0.538 | |
| vasculature development | GO:0001944 | 278 | 0.483 | |
| striated muscle tissue development | GO:0014706 | 110 | 0.462 | |
| specification of symmetry | GO:0009799 | 204 | 0.436 | |
| eye development | GO:0001654 | 277 | 0.418 | |
| morphogenesis of an epithelium | GO:0002009 | 333 | 0.418 | |
| embryonic heart tube development | GO:0035050 | 133 | 0.400 | |
| embryonic heart tube morphogenesis | GO:0003143 | 108 | 0.391 | |
| system process | GO:0003008 | 185 | 0.388 | |
| artery development | GO:0060840 | 22 | 0.377 | |
| muscle tissue development | GO:0060537 | 110 | 0.358 | |
| skeletal system development | GO:0001501 | 181 | 0.356 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 2 | 0.340 | |
| cell motility | GO:0048870 | 244 | 0.328 | |
| signal transduction | GO:0007165 | 455 | 0.313 | |
| determination of bilateral symmetry | GO:0009855 | 204 | 0.310 | |
| blood vessel development | GO:0001568 | 246 | 0.298 | |
| regulation of metabolic process | GO:0019222 | 359 | 0.290 | |
| regulation of multicellular organismal process | GO:0051239 | 277 | 0.273 | |
| digestive system development | GO:0055123 | 289 | 0.261 | |
| regulation of developmental process | GO:0050793 | 247 | 0.259 | |
| fin development | GO:0033333 | 77 | 0.257 | |
| tube morphogenesis | GO:0035239 | 349 | 0.248 | |
| central nervous system development | GO:0007417 | 387 | 0.238 | |
| fin morphogenesis | GO:0033334 | 53 | 0.223 | |
| retina development in camera type eye | GO:0060041 | 146 | 0.221 | |
| proepicardium development | GO:0003342 | 4 | 0.215 | |
| response to chemical | GO:0042221 | 320 | 0.214 | |
| atrioventricular valve development | GO:0003171 | 11 | 0.211 | |
| muscle structure development | GO:0061061 | 196 | 0.211 | |
| locomotion | GO:0040011 | 313 | 0.208 | |
| cellular nitrogen compound metabolic process | GO:0034641 | 290 | 0.208 | |
| embryonic organ morphogenesis | GO:0048562 | 274 | 0.198 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 3 | 0.195 | |
| striated muscle contraction | GO:0006941 | 12 | 0.188 | |
| embryonic organ development | GO:0048568 | 381 | 0.184 | |
| response to mechanical stimulus | GO:0009612 | 24 | 0.183 | |
| cell surface receptor signaling pathway | GO:0007166 | 325 | 0.174 | |
| vasculogenesis | GO:0001570 | 41 | 0.171 | |
| larval development | GO:0002164 | 2 | 0.169 | |
| regulation of signal transduction | GO:0009966 | 225 | 0.166 | |
| cognition | GO:0050890 | 1 | 0.164 | |
| positive regulation of biological process | GO:0048518 | 253 | 0.164 | |
| cardiac conduction system development | GO:0003161 | 1 | 0.163 | |
| cardiac muscle cell development | GO:0055013 | 20 | 0.159 | |
| determination of left right symmetry | GO:0007368 | 179 | 0.159 | |
| striated muscle cell differentiation | GO:0051146 | 129 | 0.158 | |
| pectoral fin development | GO:0033339 | 50 | 0.154 | |
| septum transversum development | GO:0003343 | 4 | 0.154 | |
| cellular component movement | GO:0006928 | 335 | 0.152 | |
| muscle organ development | GO:0007517 | 101 | 0.148 | |
| regulation of stem cell proliferation | GO:0072091 | 2 | 0.147 | |
| regulation of biological quality | GO:0065008 | 263 | 0.146 | |
| ion transport | GO:0006811 | 114 | 0.145 | |
| nucleobase containing compound metabolic process | GO:0006139 | 274 | 0.145 | |
| locomotor rhythm | GO:0045475 | 3 | 0.143 | |
| programmed cell death | GO:0012501 | 119 | 0.139 | |
| atrioventricular valve formation | GO:0003190 | 3 | 0.138 | |
| regulation of response to stimulus | GO:0048583 | 269 | 0.137 | |
| regulation of heart growth | GO:0060420 | 2 | 0.137 | |
| determination of heart left right asymmetry | GO:0061371 | 117 | 0.134 | |
| behavior | GO:0007610 | 74 | 0.134 | |
| regulation of rna biosynthetic process | GO:2001141 | 213 | 0.133 | |
| positive regulation of nitrogen compound metabolic process | GO:0051173 | 69 | 0.132 | |
| thyroid gland development | GO:0030878 | 12 | 0.132 | |
| negative regulation of multicellular organismal process | GO:0051241 | 69 | 0.130 | |
| homeostasis of number of cells | GO:0048872 | 62 | 0.129 | |
| regulation of macromolecule biosynthetic process | GO:0010556 | 225 | 0.128 | |
| urogenital system development | GO:0001655 | 97 | 0.127 | |
| positive regulation of multicellular organismal process | GO:0051240 | 52 | 0.126 | |
| muscle cell development | GO:0055001 | 115 | 0.126 | |
| response to abiotic stimulus | GO:0009628 | 122 | 0.126 | |
| hormone transport | GO:0009914 | 2 | 0.125 | |
| regulation of nitrogen compound metabolic process | GO:0051171 | 251 | 0.123 | |
| cellular response to organic substance | GO:0071310 | 105 | 0.122 | |
| cellular biosynthetic process | GO:0044249 | 286 | 0.122 | |
| epithelial tube morphogenesis | GO:0060562 | 148 | 0.120 | |
| positive regulation of developmental process | GO:0051094 | 50 | 0.120 | |
| digestive tract development | GO:0048565 | 265 | 0.118 | |
| gland development | GO:0048732 | 143 | 0.117 | |
| angiogenesis | GO:0001525 | 158 | 0.115 | |
| rna biosynthetic process | GO:0032774 | 181 | 0.115 | |
| sarcomere organization | GO:0045214 | 26 | 0.113 | |
| cellular response to chemical stimulus | GO:0070887 | 157 | 0.113 | |
| neurological system process | GO:0050877 | 62 | 0.112 | |
| pericardium morphogenesis | GO:0003344 | 1 | 0.112 | |
| sensory organ development | GO:0007423 | 393 | 0.112 | |
| response to stress | GO:0006950 | 263 | 0.112 | |
| regulation of heart morphogenesis | GO:2000826 | 17 | 0.111 | |
| cellular component morphogenesis | GO:0032989 | 336 | 0.111 | |
| cellular response to growth factor stimulus | GO:0071363 | 39 | 0.107 | |
| organic cyclic compound metabolic process | GO:1901360 | 301 | 0.107 | |
| heterocycle metabolic process | GO:0046483 | 290 | 0.106 | |
| stem cell differentiation | GO:0048863 | 117 | 0.105 | |
| pronephros development | GO:0048793 | 69 | 0.105 | |
| negative regulation of cell death | GO:0060548 | 60 | 0.104 | |
| brain development | GO:0007420 | 293 | 0.104 | |
| cellular aromatic compound metabolic process | GO:0006725 | 295 | 0.102 | |
| cardiac chamber formation | GO:0003207 | 4 | 0.101 | |
| cellular response to endogenous stimulus | GO:0071495 | 68 | 0.100 | |
| cell death | GO:0008219 | 121 | 0.100 | |
| protein modification process | GO:0036211 | 100 | 0.099 | |
| myeloid cell differentiation | GO:0030099 | 86 | 0.099 | |
| blood vessel morphogenesis | GO:0048514 | 216 | 0.098 | |
| kidney development | GO:0001822 | 92 | 0.098 | |
| water homeostasis | GO:0030104 | 4 | 0.097 | |
| response to external stimulus | GO:0009605 | 264 | 0.096 | |
| appendage development | GO:0048736 | 80 | 0.096 | |
| stem cell maintenance | GO:0019827 | 4 | 0.096 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 4 | 0.094 | |
| single organism metabolic process | GO:0044710 | 217 | 0.093 | |
| regulation of cell communication | GO:0010646 | 232 | 0.092 | |
| cell morphogenesis | GO:0000902 | 289 | 0.092 | |
| regulation of endothelial cell differentiation | GO:0045601 | 3 | 0.091 | |
| cell migration involved in gastrulation | GO:0042074 | 79 | 0.091 | |
| regulation of system process | GO:0044057 | 40 | 0.090 | |
| aging | GO:0007568 | 2 | 0.089 | |
| death | GO:0016265 | 121 | 0.089 | |
| mesenchyme development | GO:0060485 | 127 | 0.089 | |
| heterophilic cell cell adhesion via plasma membrane cell adhesion molecules | GO:0007157 | 2 | 0.088 | |
| transmembrane transport | GO:0055085 | 120 | 0.088 | |
| heterocycle biosynthetic process | GO:0018130 | 215 | 0.086 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 2 | 0.086 | |
| camera type eye development | GO:0043010 | 222 | 0.085 | |
| response to drug | GO:0042493 | 3 | 0.085 | |
| negative regulation of developmental process | GO:0051093 | 65 | 0.084 | |
| appendage morphogenesis | GO:0035107 | 56 | 0.082 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 2 | 0.082 | |
| regulation of phosphorus metabolic process | GO:0051174 | 43 | 0.081 | |
| nucleic acid templated transcription | GO:0097659 | 181 | 0.078 | |
| regulation of gene expression | GO:0010468 | 265 | 0.077 | |
| positive regulation of heart contraction | GO:0045823 | 2 | 0.077 | |
| regulation of blood pressure | GO:0008217 | 1 | 0.077 | |
| anterior posterior pattern specification | GO:0009952 | 152 | 0.076 | |
| organic cyclic compound biosynthetic process | GO:1901362 | 223 | 0.076 | |
| cell surface receptor signaling pathway involved in heart development | GO:0061311 | 20 | 0.076 | |
| negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902176 | 2 | 0.075 | |
| striated muscle cell development | GO:0055002 | 108 | 0.074 | |
| cell proliferation involved in heart morphogenesis | GO:0061323 | 2 | 0.074 | |
| ameboidal type cell migration | GO:0001667 | 143 | 0.073 | |
| regulation of tube size | GO:0035150 | 2 | 0.073 | |
| negative regulation of programmed cell death | GO:0043069 | 58 | 0.071 | |
| regulation of skeletal muscle tissue development | GO:0048641 | 4 | 0.071 | |
| gastrulation | GO:0007369 | 208 | 0.070 | |
| biosynthetic process | GO:0009058 | 294 | 0.069 | |
| nucleic acid metabolic process | GO:0090304 | 244 | 0.068 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 2 | 0.068 | |
| regulation of nucleoside metabolic process | GO:0009118 | 2 | 0.067 | |
| rna metabolic process | GO:0016070 | 219 | 0.067 | |
| positive regulation of stem cell proliferation | GO:2000648 | 1 | 0.066 | |
| cardiac cell development | GO:0055006 | 21 | 0.066 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 195 | 0.066 | |
| cell projection organization | GO:0030030 | 284 | 0.066 | |
| pharyngeal system development | GO:0060037 | 18 | 0.066 | |
| cardiac muscle cell differentiation | GO:0055007 | 30 | 0.065 | |
| regulation of signaling | GO:0023051 | 235 | 0.065 | |
| cell part morphogenesis | GO:0032990 | 246 | 0.065 | |
| homeostatic process | GO:0042592 | 142 | 0.065 | |
| muscle contraction | GO:0006936 | 18 | 0.065 | |
| positive regulation of blood circulation | GO:1903524 | 2 | 0.064 | |
| tissue remodeling | GO:0048771 | 4 | 0.064 | |
| immune system process | GO:0002376 | 241 | 0.063 | |
| aromatic compound biosynthetic process | GO:0019438 | 217 | 0.062 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 106 | 0.062 | |
| renal system development | GO:0072001 | 94 | 0.062 | |
| photoreceptor cell fate commitment | GO:0046552 | 1 | 0.062 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 3 | 0.061 | |
| cardiac muscle fiber development | GO:0048739 | 3 | 0.061 | |
| epithelial cell differentiation | GO:0030855 | 116 | 0.060 | |
| stem cell proliferation | GO:0072089 | 4 | 0.059 | |
| regulation of multicellular organismal development | GO:2000026 | 223 | 0.059 | |
| hormone secretion | GO:0046879 | 2 | 0.058 | |
| regulation of heart contraction | GO:0008016 | 32 | 0.058 | |
| inner ear development | GO:0048839 | 126 | 0.057 | |
| neuron projection regeneration | GO:0031102 | 16 | 0.057 | |
| endocardium morphogenesis | GO:0003160 | 4 | 0.056 | |
| regulation of localization | GO:0032879 | 104 | 0.056 | |
| cell fate commitment | GO:0045165 | 99 | 0.056 | |
| negative regulation of apoptotic process | GO:0043066 | 55 | 0.055 | |
| response to antibiotic | GO:0046677 | 1 | 0.054 | |
| cellular nitrogen compound biosynthetic process | GO:0044271 | 218 | 0.054 | |
| peptide transport | GO:0015833 | 1 | 0.053 | |
| cell migration | GO:0016477 | 237 | 0.053 | |
| response to organic substance | GO:0010033 | 153 | 0.052 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 1 | 0.052 | |
| nephric duct development | GO:0072176 | 13 | 0.052 | |
| post embryonic morphogenesis | GO:0009886 | 4 | 0.052 | |
| apoptotic process | GO:0006915 | 116 | 0.051 | |
| regulation of membrane potential | GO:0042391 | 23 | 0.051 | |
| axonogenesis | GO:0007409 | 152 | 0.051 | |
| regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902175 | 2 | 0.051 | |
| exocrine pancreas development | GO:0031017 | 28 | 0.051 | |
| somite development | GO:0061053 | 96 | 0.050 | |
| gliogenesis | GO:0042063 | 45 | 0.050 | |
| endocardium development | GO:0003157 | 9 | 0.050 | |
| cell projection morphogenesis | GO:0048858 | 244 | 0.050 | |
| central nervous system neuron differentiation | GO:0021953 | 74 | 0.050 | |
| pancreas development | GO:0031016 | 84 | 0.050 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 191 | 0.050 | |
| regulation of epithelial cell proliferation | GO:0050678 | 3 | 0.049 | |
| glial cell proliferation | GO:0014009 | 4 | 0.049 | |
| negative regulation of response to stimulus | GO:0048585 | 104 | 0.049 | |
| somatic muscle development | GO:0007525 | 4 | 0.049 | |
| artery morphogenesis | GO:0048844 | 14 | 0.049 | |
| regulation of macromolecule metabolic process | GO:0060255 | 317 | 0.049 | |
| formation of primary germ layer | GO:0001704 | 62 | 0.048 | |
| endocrine pancreas development | GO:0031018 | 27 | 0.048 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 3 | 0.047 | |
| posterior lateral line neuromast development | GO:0048919 | 20 | 0.047 | |
| organic substance biosynthetic process | GO:1901576 | 289 | 0.047 | |
| inorganic ion transmembrane transport | GO:0098660 | 57 | 0.047 | |
| lipid storage | GO:0019915 | 1 | 0.046 | |
| cardiac conduction | GO:0061337 | 3 | 0.046 | |
| atrial ventricular junction remodeling | GO:0003294 | 2 | 0.046 | |
| multi organism process | GO:0051704 | 134 | 0.046 | |
| protein metabolic process | GO:0019538 | 183 | 0.046 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 130 | 0.045 | |
| intracellular signal transduction | GO:0035556 | 85 | 0.045 | |
| regulation of neurogenesis | GO:0050767 | 87 | 0.045 | |
| atrial cardiac myofibril assembly | GO:0055004 | 2 | 0.044 | |
| glomerulus vasculature development | GO:0072012 | 2 | 0.044 | |
| peripheral nervous system development | GO:0007422 | 55 | 0.044 | |
| taxis | GO:0042330 | 109 | 0.044 | |
| regulation of blood vessel size | GO:0050880 | 2 | 0.043 | |
| positive regulation of transport | GO:0051050 | 2 | 0.043 | |
| mesenchymal cell differentiation | GO:0048762 | 87 | 0.043 | |
| heart looping | GO:0001947 | 94 | 0.042 | |
| axon development | GO:0061564 | 166 | 0.042 | |
| regeneration | GO:0031099 | 91 | 0.042 | |
| mitotic cell cycle process | GO:1903047 | 48 | 0.042 | |
| regulation of notch signaling pathway | GO:0008593 | 16 | 0.041 | |
| pectoral fin morphogenesis | GO:0035138 | 29 | 0.041 | |
| erythrocyte differentiation | GO:0030218 | 54 | 0.041 | |
| phosphate containing compound metabolic process | GO:0006796 | 108 | 0.041 | |
| regulation of transcription dna templated | GO:0006355 | 213 | 0.040 | |
| muscle system process | GO:0003012 | 20 | 0.040 | |
| cell adhesion | GO:0007155 | 40 | 0.040 | |
| muscle cell differentiation | GO:0042692 | 139 | 0.039 | |
| organonitrogen compound metabolic process | GO:1901564 | 74 | 0.039 | |
| regulation of apoptotic process | GO:0042981 | 98 | 0.039 | |
| positive regulation of metabolic process | GO:0009893 | 108 | 0.039 | |
| gene expression | GO:0010467 | 252 | 0.038 | |
| nuclear import | GO:0051170 | 3 | 0.038 | |
| skeletal muscle organ development | GO:0060538 | 78 | 0.038 | |
| cell cycle g1 s phase transition | GO:0044843 | 1 | 0.038 | |
| regulation of molecular function | GO:0065009 | 70 | 0.038 | |
| cellular response to hormone stimulus | GO:0032870 | 39 | 0.037 | |
| transcription dna templated | GO:0006351 | 181 | 0.037 | |
| regulation of cell differentiation | GO:0045595 | 142 | 0.037 | |
| regulation of cellular macromolecule biosynthetic process | GO:2000112 | 222 | 0.037 | |
| cellular protein metabolic process | GO:0044267 | 129 | 0.037 | |
| mesenchymal cell proliferation | GO:0010463 | 1 | 0.037 | |
| negative regulation of heart contraction | GO:0045822 | 2 | 0.037 | |
| regulation of phosphate metabolic process | GO:0019220 | 43 | 0.037 | |
| positive regulation of macromolecule biosynthetic process | GO:0010557 | 59 | 0.037 | |
| hemopoiesis | GO:0030097 | 183 | 0.037 | |
| heart field specification | GO:0003128 | 1 | 0.036 | |
| regulation of protein transport | GO:0051223 | 3 | 0.036 | |
| positive regulation of cellular metabolic process | GO:0031325 | 94 | 0.036 | |
| response to growth factor | GO:0070848 | 39 | 0.036 | |
| phosphorus metabolic process | GO:0006793 | 109 | 0.036 | |
| maintenance of location | GO:0051235 | 4 | 0.036 | |
| regulation of reproductive process | GO:2000241 | 4 | 0.035 | |
| motor neuron axon guidance | GO:0008045 | 23 | 0.035 | |
| pericardium development | GO:0060039 | 1 | 0.035 | |
| stem cell division | GO:0017145 | 1 | 0.035 | |
| macromolecule modification | GO:0043412 | 111 | 0.035 | |
| neuron projection morphogenesis | GO:0048812 | 161 | 0.035 | |
| invagination involved in gastrulation with mouth forming second | GO:0055109 | 1 | 0.035 | |
| positive regulation of biosynthetic process | GO:0009891 | 68 | 0.035 | |
| positive regulation of macromolecule metabolic process | GO:0010604 | 93 | 0.035 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 7 | 0.035 | |
| positive regulation of cell proliferation | GO:0008284 | 15 | 0.035 | |
| cardiac cell fate commitment | GO:0060911 | 1 | 0.034 | |
| cellular response to stress | GO:0033554 | 62 | 0.034 | |
| regulation of rna metabolic process | GO:0051252 | 224 | 0.034 | |
| chordate embryonic development | GO:0043009 | 271 | 0.034 | |
| atrioventricular valve morphogenesis | GO:0003181 | 6 | 0.034 | |
| cell matrix adhesion | GO:0007160 | 4 | 0.034 | |
| regulation of hormone levels | GO:0010817 | 21 | 0.034 | |
| positive regulation of cellular process | GO:0048522 | 201 | 0.033 | |
| negative regulation of muscle tissue development | GO:1901862 | 2 | 0.033 | |
| membrane repolarization | GO:0086009 | 2 | 0.033 | |
| inositol lipid mediated signaling | GO:0048017 | 2 | 0.033 | |
| response to steroid hormone | GO:0048545 | 35 | 0.033 | |
| mesoderm morphogenesis | GO:0048332 | 51 | 0.033 | |
| response to lipid | GO:0033993 | 60 | 0.033 | |
| positive regulation of map kinase activity | GO:0043406 | 3 | 0.033 | |
| positive regulation of gene expression | GO:0010628 | 71 | 0.032 | |
| outflow tract morphogenesis | GO:0003151 | 1 | 0.032 | |
| morphogenesis of an epithelial sheet | GO:0002011 | 49 | 0.032 | |
| transport | GO:0006810 | 220 | 0.032 | |
| mechanosensory behavior | GO:0007638 | 2 | 0.032 | |
| collagen metabolic process | GO:0032963 | 2 | 0.032 | |
| head development | GO:0060322 | 303 | 0.032 | |
| ear development | GO:0043583 | 127 | 0.032 | |
| organ formation | GO:0048645 | 17 | 0.032 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 38 | 0.032 | |
| cytosolic calcium ion transport | GO:0060401 | 3 | 0.032 | |
| embryonic hemopoiesis | GO:0035162 | 53 | 0.032 | |
| regulation of circadian rhythm | GO:0042752 | 4 | 0.032 | |
| glial cell migration | GO:0008347 | 3 | 0.032 | |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 2 | 0.032 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 0 | 0.031 | |
| endoderm formation | GO:0001706 | 29 | 0.031 | |
| muscle fiber development | GO:0048747 | 52 | 0.031 | |
| cell cycle | GO:0007049 | 93 | 0.031 | |
| nerve development | GO:0021675 | 45 | 0.031 | |
| posterior lateral line development | GO:0048916 | 38 | 0.031 | |
| regulation of growth | GO:0040008 | 42 | 0.031 | |
| response to oxygen containing compound | GO:1901700 | 55 | 0.030 | |
| exocrine system development | GO:0035272 | 28 | 0.030 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 68 | 0.030 | |
| positive regulation of secretion by cell | GO:1903532 | 1 | 0.030 | |
| regulation of protein metabolic process | GO:0051246 | 56 | 0.030 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 1 | 0.030 | |
| positive regulation of response to stimulus | GO:0048584 | 80 | 0.029 | |
| regulation of cell death | GO:0010941 | 103 | 0.029 | |
| regulation of myotube differentiation | GO:0010830 | 2 | 0.029 | |
| lipid catabolic process | GO:0016042 | 4 | 0.029 | |
| forebrain development | GO:0030900 | 96 | 0.029 | |
| chemosensory behavior | GO:0007635 | 1 | 0.029 | |
| regulation of cell morphogenesis | GO:0022604 | 42 | 0.029 | |
| cellular component assembly | GO:0022607 | 170 | 0.029 | |
| regulation of cell adhesion | GO:0030155 | 15 | 0.029 | |
| response to oxygen levels | GO:0070482 | 25 | 0.028 | |
| cellular macromolecule biosynthetic process | GO:0034645 | 224 | 0.028 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.028 | |
| feeding behavior | GO:0007631 | 5 | 0.028 | |
| photoreceptor cell differentiation | GO:0046530 | 55 | 0.028 | |
| regulation of developmental growth | GO:0048638 | 38 | 0.028 | |
| eye photoreceptor cell development | GO:0042462 | 30 | 0.028 | |
| intermediate mesoderm development | GO:0048389 | 2 | 0.028 | |
| mesodermal to mesenchymal transition involved in gastrulation | GO:0060809 | 1 | 0.028 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 271 | 0.028 | |
| response to decreased oxygen levels | GO:0036293 | 25 | 0.028 | |
| sarcomerogenesis | GO:0048769 | 4 | 0.028 | |
| otolith development | GO:0048840 | 32 | 0.027 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 1 | 0.027 | |
| single organism organelle organization | GO:1902589 | 199 | 0.027 | |
| regulation of epidermis development | GO:0045682 | 2 | 0.027 | |
| pharyngeal muscle development | GO:0043282 | 4 | 0.027 | |
| neuron development | GO:0048666 | 262 | 0.027 | |
| myofibril assembly | GO:0030239 | 48 | 0.026 | |
| regulation of nucleotide catabolic process | GO:0030811 | 2 | 0.026 | |
| phosphorylation | GO:0016310 | 69 | 0.026 | |
| specification of organ identity | GO:0010092 | 2 | 0.026 | |
| epithelial to mesenchymal transition | GO:0001837 | 21 | 0.026 | |
| cellular aldehyde metabolic process | GO:0006081 | 4 | 0.026 | |
| posterior lateral line system development | GO:0048915 | 46 | 0.026 | |
| mesenchymal cell development | GO:0014031 | 78 | 0.026 | |
| neuron fate commitment | GO:0048663 | 26 | 0.026 | |
| regulation of cell projection assembly | GO:0060491 | 4 | 0.026 | |
| localization of cell | GO:0051674 | 244 | 0.026 | |
| positive regulation of nucleic acid templated transcription | GO:1903508 | 57 | 0.025 | |
| neural retina development | GO:0003407 | 49 | 0.025 | |
| endocrine system development | GO:0035270 | 65 | 0.025 | |
| morphogenesis of an epithelial fold | GO:0060571 | 1 | 0.025 | |
| segmentation | GO:0035282 | 97 | 0.025 | |
| heart formation | GO:0060914 | 13 | 0.025 | |
| cell cycle phase transition | GO:0044770 | 9 | 0.025 | |
| establishment of protein localization to organelle | GO:0072594 | 4 | 0.025 | |
| stem cell development | GO:0048864 | 82 | 0.025 | |
| inner ear morphogenesis | GO:0042472 | 63 | 0.025 | |
| cellular macromolecule metabolic process | GO:0044260 | 391 | 0.025 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 4 | 0.025 | |
| heart valve morphogenesis | GO:0003179 | 8 | 0.024 | |
| positive regulation of nucleobase containing compound metabolic process | GO:0045935 | 69 | 0.024 | |
| actomyosin structure organization | GO:0031032 | 53 | 0.024 | |
| regulation of calcium ion transport | GO:0051924 | 2 | 0.024 | |
| antimicrobial humoral response | GO:0019730 | 2 | 0.024 | |
| positive regulation of striated muscle tissue development | GO:0045844 | 1 | 0.024 | |
| response to endogenous stimulus | GO:0009719 | 83 | 0.024 | |
| nephron tubule morphogenesis | GO:0072078 | 1 | 0.024 | |
| convergent extension | GO:0060026 | 118 | 0.024 | |
| heart valve development | GO:0003170 | 14 | 0.024 | |
| positive regulation of rna biosynthetic process | GO:1902680 | 57 | 0.024 | |
| somitogenesis | GO:0001756 | 87 | 0.024 | |
| regulation of organ morphogenesis | GO:2000027 | 35 | 0.024 | |
| response to ketone | GO:1901654 | 1 | 0.024 | |
| regulation of muscle contraction | GO:0006937 | 3 | 0.024 | |
| negative regulation of nervous system development | GO:0051961 | 22 | 0.024 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 2 | 0.024 | |
| regulation of nucleobase containing compound metabolic process | GO:0019219 | 250 | 0.024 | |
| growth | GO:0040007 | 174 | 0.024 | |
| regulation of organ growth | GO:0046620 | 3 | 0.024 | |
| eye morphogenesis | GO:0048592 | 144 | 0.023 | |
| astrocyte differentiation | GO:0048708 | 1 | 0.023 | |
| regulation of kinase activity | GO:0043549 | 15 | 0.023 | |
| regulation of nucleic acid templated transcription | GO:1903506 | 213 | 0.023 | |
| regulation of programmed cell death | GO:0043067 | 101 | 0.023 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 107 | 0.023 | |
| retinal rod cell development | GO:0046548 | 4 | 0.023 | |
| compound eye development | GO:0048749 | 2 | 0.023 | |
| guanosine containing compound metabolic process | GO:1901068 | 4 | 0.023 | |
| cartilage development | GO:0051216 | 96 | 0.023 | |
| regulation of primary metabolic process | GO:0080090 | 311 | 0.023 | |
| positive regulation of epithelial cell migration | GO:0010634 | 2 | 0.023 | |
| positive regulation of muscle organ development | GO:0048636 | 1 | 0.023 | |
| detection of mechanical stimulus | GO:0050982 | 11 | 0.022 | |
| regulation of wound healing | GO:0061041 | 2 | 0.022 | |
| endocardial cushion formation | GO:0003272 | 2 | 0.022 | |
| regulation of multicellular organism growth | GO:0040014 | 4 | 0.022 | |
| response to glucocorticoid | GO:0051384 | 1 | 0.022 | |
| cardiac atrium morphogenesis | GO:0003209 | 2 | 0.022 | |
| small molecule metabolic process | GO:0044281 | 77 | 0.022 | |
| positive regulation of cell adhesion | GO:0045785 | 1 | 0.022 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 2 | 0.022 | |
| axial mesoderm development | GO:0048318 | 10 | 0.022 | |
| arterial endothelial cell differentiation | GO:0060842 | 2 | 0.022 | |
| eye photoreceptor cell differentiation | GO:0001754 | 45 | 0.022 | |
| lateral line system development | GO:0048925 | 76 | 0.022 | |
| inner ear receptor cell fate commitment | GO:0060120 | 4 | 0.022 | |
| cell proliferation | GO:0008283 | 80 | 0.022 | |
| cranial nerve development | GO:0021545 | 42 | 0.022 | |
| humoral immune response | GO:0006959 | 5 | 0.021 | |
| regulation of cytoplasmic transport | GO:1903649 | 4 | 0.021 | |
| regulation of meiotic cell cycle | GO:0051445 | 1 | 0.021 | |
| retina morphogenesis in camera type eye | GO:0060042 | 79 | 0.021 | |
| negative regulation of growth rate | GO:0045967 | 1 | 0.021 | |
| nephron development | GO:0072006 | 31 | 0.021 | |
| regulation of phospholipase c activity | GO:1900274 | 1 | 0.021 | |
| regulation of heart rate | GO:0002027 | 5 | 0.021 | |
| organelle organization | GO:0006996 | 227 | 0.021 | |
| regulation of response to oxidative stress | GO:1902882 | 2 | 0.021 | |
| photoreceptor cell fate specification | GO:0043704 | 1 | 0.021 | |
| adult behavior | GO:0030534 | 2 | 0.020 | |
| neuron fate determination | GO:0048664 | 2 | 0.020 | |
| response to alkaloid | GO:0043279 | 2 | 0.020 | |
| myeloid cell homeostasis | GO:0002262 | 56 | 0.020 | |
| developmental growth involved in morphogenesis | GO:0060560 | 86 | 0.020 | |
| regulation of cell migration | GO:0030334 | 40 | 0.020 | |
| gtp catabolic process | GO:0006184 | 2 | 0.020 | |
| transcription from rna polymerase ii promoter | GO:0006366 | 80 | 0.020 | |
| regulation of cell proliferation | GO:0042127 | 37 | 0.020 | |
| embryonic appendage morphogenesis | GO:0035113 | 30 | 0.019 | |
| endocardial cushion morphogenesis | GO:0003203 | 3 | 0.019 | |
| biological adhesion | GO:0022610 | 40 | 0.019 | |
| negative regulation of cell communication | GO:0010648 | 96 | 0.019 | |
| locomotory behavior | GO:0007626 | 34 | 0.019 | |
| regulation of cellular protein metabolic process | GO:0032268 | 52 | 0.019 | |
| negative regulation of cellular process | GO:0048523 | 283 | 0.019 | |
| negative regulation of secretion | GO:0051048 | 2 | 0.019 | |
| glycosaminoglycan biosynthetic process | GO:0006024 | 8 | 0.019 | |
| cell death in response to oxidative stress | GO:0036473 | 2 | 0.019 | |
| actin cytoskeleton organization | GO:0030036 | 63 | 0.019 | |
| positive regulation of rna metabolic process | GO:0051254 | 59 | 0.019 | |
| calcium ion import | GO:0070509 | 4 | 0.019 | |
| mesoderm formation | GO:0001707 | 43 | 0.019 | |
| cellular response to vascular endothelial growth factor stimulus | GO:0035924 | 3 | 0.019 | |
| atrial cardiac muscle cell development | GO:0055014 | 4 | 0.019 | |
| neuromuscular synaptic transmission | GO:0007274 | 2 | 0.019 | |
| digestive tract morphogenesis | GO:0048546 | 231 | 0.019 | |
| cellular component biogenesis | GO:0044085 | 178 | 0.019 | |
| regulation of metal ion transport | GO:0010959 | 4 | 0.019 | |
| lymphocyte homeostasis | GO:0002260 | 1 | 0.019 | |
| neuromast development | GO:0048884 | 46 | 0.018 | |
| gland morphogenesis | GO:0022612 | 13 | 0.018 | |
| negative regulation of biological process | GO:0048519 | 304 | 0.018 | |
| positive regulation of catalytic activity | GO:0043085 | 25 | 0.018 | |
| regulation of biosynthetic process | GO:0009889 | 250 | 0.018 | |
| dna templated transcription initiation | GO:0006352 | 1 | 0.018 | |
| divalent metal ion transport | GO:0070838 | 20 | 0.018 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 1 | 0.018 | |
| regulation of behavior | GO:0050795 | 24 | 0.018 | |
| female sex differentiation | GO:0046660 | 4 | 0.018 | |
| transmission of nerve impulse | GO:0019226 | 19 | 0.018 | |
| positive regulation of cell cycle | GO:0045787 | 3 | 0.018 | |
| developmental growth | GO:0048589 | 166 | 0.018 | |
| nucleobase containing compound biosynthetic process | GO:0034654 | 205 | 0.018 | |
| response to hormone | GO:0009725 | 48 | 0.018 | |
| muscle cell fate determination | GO:0007521 | 1 | 0.018 | |
| regulation of cell shape | GO:0008360 | 1 | 0.017 | |
| aorta development | GO:0035904 | 4 | 0.017 | |
| blood vessel endothelial cell differentiation | GO:0060837 | 2 | 0.017 | |
| positive regulation of nervous system development | GO:0051962 | 25 | 0.017 | |
| protein targeting to nucleus | GO:0044744 | 3 | 0.017 | |
| cellular response to antibiotic | GO:0071236 | 1 | 0.017 | |
| regionalization | GO:0003002 | 274 | 0.017 | |
| guanosine containing compound catabolic process | GO:1901069 | 2 | 0.017 | |
| cytoskeleton organization | GO:0007010 | 96 | 0.017 | |
